Legend Biotech Corp. ADR (LEGN) Social Stream
LEGEND BIOTECH CORP (LEGN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LEGN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 4 | $56 | $50 | $53 | $56.44 | -6.09% |
| 2021-11-19 | 4 | $61 | $51 | $55.75 | $56.44 | -1.22% |
| 2021-11-26 | 5 | $71 | $51 | $59.5 | $56.44 | 5.42% |
| 2022-01-06 | 5 | $71 | $51 | $60.8 | $56.44 | 7.73% |
| 2022-02-16 | 5 | $71 | $51 | $60.8 | $56.44 | 7.73% |
| 2022-03-01 | 5 | $72 | $51 | $62 | $56.44 | 9.85% |
| 2022-03-07 | 5 | $73 | $55 | $63.2 | $56.44 | 11.98% |
| 2022-04-19 | 6 | $73 | $53 | $61.5 | $56.44 | 8.97% |
| 2022-06-06 | 4 | $73 | $53 | $62.8 | $56.44 | 11.27% |
| 2022-06-17 | 6 | $77 | $53 | $65.166 | $56.44 | 15.46% |
| 2022-07-15 | 6 | $77 | $53 | $67.6 | $56.44 | 19.77% |
| 2022-10-04 | 6 | $77 | $53 | $66.5 | $56.44 | 17.82% |
| 2022-10-19 | 7 | $77 | $53 | $66 | $56.44 | 16.94% |
| 2022-11-29 | 10 | $77 | $53 | $66 | $56.44 | 16.94% |
| 2022-12-13 | 10 | $77 | $53 | $66.571 | $56.44 | 17.95% |
| 2023-01-05 | 10 | $78 | $53 | $67.428 | $56.44 | 19.47% |
| 2023-01-24 | 10 | $78 | $53 | $68.142 | $56.44 | 20.73% |
| 2023-01-25 | 10 | $78 | $65 | $69.857 | $56.44 | 23.77% |
| 2023-03-29 | 10 | $78 | $65 | $69.375 | $56.44 | 22.92% |
| 2023-04-03 | 11 | $78 | $65 | $69.375 | $56.44 | 22.92% |
| 2023-04-18 | 11 | $78 | $65 | $69.777 | $56.44 | 23.63% |
| 2023-04-20 | 12 | $85 | $65 | $73.9 | $56.44 | 30.94% |
| 2023-04-25 | 12 | $90 | $65 | $75.2 | $56.44 | 33.24% |
| 2023-05-18 | 13 | $90 | $65 | $75.2 | $56.44 | 33.24% |
| 2023-05-22 | 13 | $90 | $65 | $77.7 | $56.44 | 37.67% |
| 2023-05-25 | 15 | $90 | $64 | $77.363 | $56.44 | 37.07% |
| 2023-06-08 | 15 | $90 | $64 | $79.272 | $56.44 | 40.45% |
| 2023-06-13 | 14 | $90 | $64 | $79.7 | $56.44 | 41.21% |
| 2023-07-20 | 14 | $90 | $64 | $81.7 | $56.44 | 44.76% |
| 2023-07-21 | 14 | $93 | $64 | $83 | $56.44 | 47.06% |
| 2023-08-16 | 14 | $93 | $64 | $83.2 | $56.44 | 47.41% |
| 2023-10-19 | 14 | $93 | $64 | $83.4 | $56.44 | 47.77% |
| 2023-11-15 | 15 | $93 | $64 | $83.5 | $56.44 | 47.94% |
| 2023-11-21 | 16 | $93 | $64 | $83.5 | $56.44 | 47.94% |
| 2023-12-01 | 16 | $93 | $76 | $87.109 | $56.44 | 54.34% |
| 2023-12-11 | 16 | $93 | $76 | $87.709 | $56.44 | 55.4% |
| 2023-12-19 | 17 | $93 | $65 | $85.174 | $56.44 | 50.91% |
The Trend in the Analyst Price Target
LEGN's average price target has moved up $18.22 over the prior 52 weeks.
Over the past 47 weeks, LEGN's average upside potential has been 26.81%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-25 | 10 | 78 | 65 | 69.857 | 53.25 | 31.19% |
| 2023-05-25 | 15 | 90 | 64 | 77.363 | 63.28 | 22.26% |
| 2023-07-21 | 14 | 93 | 64 | 83.000 | 74.66 | 11.17% |
| 2023-07-21 | 13 | 93 | 64 | 83.200 | 74.66 | 11.44% |
| 2023-12-19 | 17 | 93 | 65 | 85.644 | 61.76 | 38.67% |
LEGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.41 | 13 | 1 | 3 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
LEGN's average broker recommendation rating worsened by 0.01 over the prior 52 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how LEGEND BIOTECH CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -770.82% of that group.
- LEGEND BIOTECH CORP's average analyst price target is greater than 4039.01% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, LEGEND BIOTECH CORP's number of analysts covering the stock is greater than 3235.23% of them.
- LEGEND BIOTECH CORP's upside potential (average analyst target price relative to current price) is greater than 1281.88% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LEGEND BIOTECH CORP are CVAC, QGEN, and IDXX.
View All Top Stocks by Price Target
Is LEGN a Buy, Hold or Sell? See the POWR Ratings now!